Development of a Personalized Pharmacologic Treatment Repository for Bronchial Asthma Based on the 2018 Guideline for the Diagnosis and Management of Bronchial Asthma in Primary Care(Practice Edition)
Bronchial asthma is a chronic inflammatory disease with high heterogeneity, polygenic inheritance, complex etiology and many complications. The effects of prevention and treatment for a bronchial asthma patient often depend on whether the patient has received a personalized health management. In ord...
Main Author: | HUO Hongmin, YANG Yaofang, DONG Jiatian, MAO Zixian, HU Ping, SONG Fengchun |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese General Practice Publishing House Co., Ltd
2022-04-01
|
Series: | Zhongguo quanke yixue |
Subjects: | |
Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/yx20220147.pdf |
Similar Items
-
Identifying Predictors of Response to Suplatast Tosilate among Patients with Moderate to Severe Bronchial Asthma Receiving Inhaled Steroid Therapy
by: Takemasa Nakagawa, et al.
Published: (2005-01-01) -
A pharmacovigilance study on patients of bronchial asthma in a teaching hospital
by: A N Jamali, et al.
Published: (2010-01-01) -
Assessment of Factors Affecting Symptom Control in Asthmatic Patients
by: Waqas Rasheed, et al.
Published: (2020-12-01) -
Perception of primary care physicians about guidelines of bronchial asthma
by: Fahad Nasser Almutawa, et al.
Published: (2014-03-01) -
Thiotropium in bronchial asthma
by: S N Avdeev, et al.
Published: (2009-03-01)